If I were you I’d be looking at an entry point about now. It’s...

If I were you I’d be looking at an entry point about now. It’s rarely tipped below 1.60 in the last few months and there’s no reason for holders to sell now. A bunch of factors will bounce the shares - med can license any time, US pro-hemp legislation, a good EOFY report is almost a given, god knows what else they’ve been up to on the quiet. The only problem with EXL is they don’t inform shareholders and the market of all the great stuff going on (eg advertising in Japan!).